IRIS
MINICUCCI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.961
Totale 5.961
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.961
Totale 5.961
Salva come PNG Salva come JPEG
Città #
Genova 4.300
Rapallo 727
Genoa 547
Vado Ligure 363
Bordighera 24
Totale 5.961
Salva come PNG Salva come JPEG
Nome #
Abnormal activation of calpain and protein kinase Cα promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients 166
Evidence for alteration of calpain/calpastatin system in PBMC of cystic fibrosis patients 155
Phenotype/Genotype Correlation and Cystic Fibrosis Related Diabetes Mellitus (Italian Multicenter Study) 150
Calpain inhibition promotes the rescue of F(508)del-CFTR in PBMC from cystic fibrosis patients. 149
Impact of inhaled corticosteroids on the risk of early Pseudomonas Aeruginosa acquisition in cystic fibrosis 141
Younger age at diagnosis of Type 1 diabetes mellitus in children of immigrated families born in Italy. 134
Pathological role of the calpain/calpastatin system in cystic fibrosis 134
Home nebulizer use and bacterial colonization in cystic fibrosis. 130
Caregiver burden and vocational participation among parents of adolescents with CF 128
Diabetes mellitus after kidney transplantation in pediatric recipients 127
Validation of a predictive survival model in Italian patients with cystic fibrosis 125
Discharge report accuracy 123
Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an italian Cystic Fibrosis Center 122
Blood Ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study) 121
High incidence of childhood type 1 diabetes in Liguria, Italy, from 1989 to 1998 120
Discrepancy between sensitization to inhaled allergens and respiratory symptoms in pediatric patients with type 1 diabetes mellitus. 120
The calpain-calpastatin system in cystic fibrosis: physiopathological implications 118
Antimicrobial use and Pseudomonas Aeruginosa susceptibility profile in a cystic fibrosis centre 115
FùPhenotype-genotype correlation and cystic fibrosis related diabetes (CFRD) 114
Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for phe508del CFTR 114
Vitamin D receptor polymorphisms: are they really associated with type 1 diabetes? 109
N1303K MUTATION AND DIABETES MELLITUS IN CYSTIC FIBROSIS. 107
Alcaligenes xylosoxidans ed evoluzione della lesione polmonare in fibrosi cistica. 105
Investigation of risk factors associated with different HLA genotypes of susceptibility to Type 1 diabetes (The DIABFIN Project). 105
Length of gestation and gender are associated with HLA genotypes at risk for Type 1 diabetes (Italian DIABFIN 3). 105
Oxidative stress and antioxidant therapy in cystic fibrosis. 104
Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial. 100
Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis. 98
Controlled clinical study on the activity of a new mucoregulating drug in obstructive bronchial pathology with a marked hypersecretory feature. The pediatric experience. 98
Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results. 97
Role of home therapy with ofloxacin in patients with cystic fibrosis (CF) 95
Alta incidenza di diabete di tipo 1 in Liguria nel periodo 1989-1998 93
Beclometasone dipropionato per aerosol versus budesonide per turbohaler nella broncopneumopatia della fibrosi cistica. 92
Oral hypoglycemic agents in Cystic Fibrosis related diabetes (CFRD) 87
Beta-cell autoantibodies and diabetes mellitus family history in cystic fibrosis 87
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients Clin Chem Lab Med. 2011 Jan;49(1):49-54. 86
Liver disease as risk factor for cystic fibrosis-related diabetes development 85
Cystic Fibrosis - Related diabetes mellitus 79
Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series 75
Programmi svolti dalla II Clinica Pediatrica. 74
When should hyperglycemia be treated in cystic fibrosis? 73
Ursodeoxycholic Acid for Liver Disease Associated with Cystic Fibrosis: A Double-Rlind Multifiter Trial 72
Identification of novel WFS1 mutations in Italian children with Wolfram Syndrome 72
Identificazione di neonati a rischio genetico di diabete tipo 1 (DM1) da avviare a prevenzione primaria (studio PREVEFIN) - Dati preliminari 70
The use of ofloxacin in cystic fibrosis patients. 69
Terapia cortisteroidea inalatoria nella broncopneumopatia della fibrosi cistica: confronto tra beclometasone dipropionato per aerosol e budesonide per turbohaler. 68
Marker immunologici di diabete di tipo 1 in fibrosi cistica. 68
Nuove mutazioni del gene della wolframina in tre casi pediatrici 66
Characterization of Staphylococcus aureus small colony variant strains isolated from Italian patients attending a regional cystic fibrosis care centre. 66
Elevata incidenza del diabete mellito di tipo 1 in Liguria dal 1989 al 1998 65
The significance of 2-thiol-propionamido-acetic acid in the treatment of cystic fibrosis. 64
Ruolo di alcaligenes xylodoxidans nella broncopneumopatia cronica in fibrosi cistica. 64
Emergenze diabetologiche: chetoacidosi diabetica 64
Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols. 64
Screening for type 1 diabetes genetic rIsk in newborns of continental Italy. Primary prevention (Prevefin Italy) - preliminary data 63
Prima descrizione italiana di una nuova mutazione nel gene HNF-1beta (MODY 5) 62
Il Diabete in Fibrosi cistica 61
”Punteggi di valutazione clinica nella Fibrosi Cistica”. 58
Study of efficacy of piperacillin in the treatment of severe infections of the child and of the young adult 56
The adolescent with type 1 diabetes mellitus. 56
Usefulness of blood ketone bodies for monitoring insulin therapy in patients with recent onset type 1 diabetes (a multicenter study). 56
Indagini per le funzioni epatobiliari 49
MODY e diabete non autoimmune. 46
Rheological Properties of Cystic Fibrosis Bronchial Secretion and in Vitro Drug Permeation Study: The Effect of Sodium Bicarbonate 44
Totale 5.983
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.253
article - articoli 11.622
book - libri 0
conference - conferenze 3.933
curatela - curatele 0
other - altro 163
patent - brevetti 0
selected - selezionate 0
volume - volumi 535
Totale 32.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.385 0 0 0 0 136 177 328 75 120 281 205 63
2020/2021314 18 41 9 24 14 30 18 29 32 30 25 44
2021/2022729 9 49 55 104 20 43 56 195 18 66 21 93
2022/2023862 76 63 11 136 118 177 0 55 141 9 73 3
2023/2024427 22 51 4 52 38 114 4 33 18 8 26 57
2024/2025372 65 116 36 83 72 0 0 0 0 0 0 0
Totale 5.983